Bhakti Arondekar

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 13, 2025
Do trial benefits predict real-world gains in metastatic castration resistant prostate cancer.

Sarah Axeen, Alice J Chen, Darius N Lakdawalla

|Oct 02, 2023
Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population.

Stephen J Freedland, Matthew Davis, Andrew J Epstein

|Oct 20, 2021
Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020.

Bhakti Arondekar, Mei Sheng Duh, Rachel H Bhak

|Jun 01, 2021
The value of new drugs for advanced prostate cancer.

David H Howard, Ruben G W Quek, Kathleen M Fox

Pageof 1